Monday, August 22, 2016

BRIEF-Pfizer to acquire Medivation for about $14 bln

* Medivation agrees to transaction valued at $81.50 per

Medivation share in cash, for a total enterprise value of

approximately $14 billion

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)